Naples Prognostic Score: A Novel Predictor of Survival in Patients with Triple-Negative Breast Cancer

被引:0
|
作者
Qiu, Yu [1 ,2 ]
Chen, Yan [1 ,2 ]
Shen, Haoyang [1 ,2 ]
Yan, Shuixin [1 ,2 ]
Li, Jiadi [1 ,2 ]
Wu, Weizhu [1 ,3 ]
机构
[1] Ningbo Univ, Affiliated Lihuili Hosp, Ningbo 315000, Peoples R China
[2] Ningbo Univ, Hlth Sci Ctr, Ningbo 315000, Zhejiang, Peoples R China
[3] Affiliated Lihuili Hosp, 1111 Jiangnan Rd, Ningbo 315000, Zhejiang, Peoples R China
关键词
triple-negative breast cancer; Naples prognostic score; prognostic factor; nomogram predictive model; INFLAMMATION;
D O I
10.2147/JIR.S472917
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose: This study investigated the correlation between the Naples prognostic score (NPS), clinicopathological traits, and the postoperative prognoses of patients with triple-negative breast cancer (TNBC). Based on NPS, a predictive nomogram was developed to estimate the long-term survival probabilities of patients with TNBC post-surgery. Patients and Methods: We retrospectively examined the clinical records of 223 women with TNBC treated at Ningbo Medical Center, Lihuili Hospital between January 1, 2016 and December 31, 2020. Blood tests and biochemical analyses were conducted before surgery. The prognostic nutritional index (PNI), controlling nutritional status (CONUT), neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and NPS were determined based on blood-related markers. A Kaplan-Meier survival analysis assessed the association between NPS, PNI, CONUT score, overall survival (OS), and breast cancer-specific survival (BCSS). Predictive accuracy was evaluated using the area under the receiver operating characteristic curve (AUC) and C index. The patients were randomly divided into the training and the validation group (6:4 ratio). A nomogram prediction model was developed and evaluated using the R Software for Statistical Computing (RMS) package. Results: NPS outperformed other scores in predicting inflammation outcomes. Patients with an elevated NPS had a poorer prognosis (P<0.001). Lymph node ratio (LNR), surgical method, postoperative chemotherapy, and NPS independently predicted OS, whereas M stage, LNR, and NPS independently predicted BCSS outcome. The OS and BCSS predicted by the nomogram model aligned well with the actual OS and BCSS. The decision curve analysis showed significant clinical utility for the nomogram model. Conclusion: In this study, NPS was an important prognostic indicator for patients with TNBC. The nomogram prognostic model based on NPS outperformed other prognostic scores for predicting patient prognosis. The model demonstrated a clear stratification ability for patient prognosis, which emphasized the potential benefits of early intervention for high-risk patients. Plain Language Summary: In this study, we aimed to understand how the Naples prognostic score (NPS) scoring system could predict the prognosis for patients with triple-negative breast cancer (TNBC). TNBC is a type of breast cancer that can be difficult to treat. Medical records of 223 women with TNBC were retrospectively analyzed. These women had their blood tested before surgery to check for certain markers related to nutrition and inflammation. NPS was used along with other scores to determine their accuracy in predicting survival. NPS was better at predicting outcomes than the other scores. The patients with higher NPS scores tended to have poorer outcomes. We also created a visual tool called a nomogram to help doctors predict patient outcomes based on the NPS scores. NPS can be a valuable tool for doctors treating patients with TNBC because it can help them predict how well a patient might do after surgery. This information could be used to tailor treatment plans for these patients. The nomogram provides a user-friendly way for doctors to use NPS in their practice. Overall, this study showed that NPS is a powerful tool for predicting outcomes for patients with TNBC, which could lead to better treatment decisions and improved outcomes for these patients.
引用
下载
收藏
页码:5253 / 5269
页数:17
相关论文
共 50 条
  • [1] Naples prognostic score: a novel predictor of survival in patients with HER2-positive breast cancer
    Chen, Yuye
    Guan, Zheming
    Shen, Guo
    FUTURE ONCOLOGY, 2022, 18 (21) : 2655 - 2665
  • [2] Novel prognostic markers for patients with triple-negative breast cancer
    Zhou, Ling
    Li, Ke
    Luo, Yanli
    Tian, Ling
    Wang, Min
    Li, Chuanyuan
    Huang, Qian
    HUMAN PATHOLOGY, 2013, 44 (10) : 2180 - 2187
  • [3] Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer
    Patel, Dilan A.
    Xi, Jing
    Luo, Jingqin
    Hassan, Bilal
    Thomas, Shana
    Ma, Cynthia X.
    Campian, Jian L.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 174 (02) : 443 - 452
  • [4] Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer
    Dilan A. Patel
    Jing Xi
    Jingqin Luo
    Bilal Hassan
    Shana Thomas
    Cynthia X. Ma
    Jian L. Campian
    Breast Cancer Research and Treatment, 2019, 174 : 443 - 452
  • [5] Novel prognostic stromal subtypes in triple-negative breast cancer
    Thompson, Crista
    Saleh, Sadiq M.
    Bertos, Nicholas
    Gigoux, Mathieu
    Gruosso, Tina
    Souleimanova, Margarita
    Zhao, Hong
    Hallett, Michael T.
    Park, Morag
    CANCER RESEARCH, 2016, 76
  • [6] Deep survival model indentified the prognostic subgroups in triple-negative breast cancer patients
    Kim, I.
    Ryu, J. M.
    Choi, H. J.
    Kim, J. M.
    Lee, S. K.
    Yu, J. H.
    Kim, S. W.
    Nam, S. J.
    Lee, J. E.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S26 - S26
  • [7] Potential prognostic markers for recurrence and survival in triple-negative breast cancer
    Havrysh, K. V.
    Mukhametshina, G.
    Safina, S.
    Petrov, S.
    Kiyamova, R. G.
    ANNALS OF ONCOLOGY, 2018, 29
  • [8] Update of survival and prognostic factors of triple-negative breast cancer in Thailand
    Rojratsirikul, C.
    Jaisthaporn, K.
    Pornpraserthsuk, P.
    Sinthusake, T.
    Cheirsilpa, A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 312 - 312
  • [9] TTK is a favorable prognostic biomarker for triple-negative breast cancer survival
    Xu, Qianqian
    Xu, Yali
    Pan, Bo
    Wu, Liangcai
    Ren, Xinyu
    Zhou, Yidong
    Mao, Feng
    Lin, Yan
    Guan, Jinghong
    Shen, Songjie
    Zhang, Xiaohui
    Wang, Changjun
    Zhong, Ying
    Zhou, Liangrui
    Liang, Zhiyong
    Zhao, Haitao
    Sun, Qiang
    ONCOTARGET, 2016, 7 (49) : 81815 - 81829
  • [10] CYPOR is a novel and independent prognostic biomarker of recurrence-free survival in triple-negative breast cancer patients
    Pedersen, Martin H.
    Hood, Brian L.
    Ehmsen, Sidse
    Beck, Hans C.
    Conrads, Thomas P.
    Bak, Martin
    Ditzel, Henrik J.
    Leth-Larsen, Rikke
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (03) : 631 - 640